TY  - JOUR
A1  - Michel, R.
A1  - Wachter, E.
A1  - Sebald, Walter
T1  - Synthesis of a larger precursor for the proteolipid subunit of the mitochondrial ATPase complex of Neurospora crassa in a cell-free wheat germ system
N2  - No abstract available
KW  - Biochemie
Y1  - 1979
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62789
ER  - 
TY  - JOUR
A1  - Angelika, Kronhardt
A1  - Rolando, Monica
A1  - Beitzinger, Christoph
A1  - Stefani, Caroline
A1  - Leuber, Michael
A1  - Flatau, Gilles
A1  - Popoff, Michel R.
A1  - Benz, Roland
A1  - Lemichez, Emmanuel
T1  - Cross-Reactivity of Anthrax and C2 Toxin: Protective Antigen Promotes the Uptake of Botulinum C2I Toxin into Human Endothelial Cells
JF  - PLoS ONE
N2  - Binary toxins are among the most potent bacterial protein toxins performing a cooperative mode of translocation and exhibit fatal enzymatic activities in eukaryotic cells. Anthrax and C2 toxin are the most prominent examples for the AB(7/8) type of toxins. The B subunits bind both host cell receptors and the enzymatic A polypeptides to trigger their internalization and translocation into the host cell cytosol. C2 toxin is composed of an actin ADP-ribosyltransferase (C2I) and C2II binding subunits. Anthrax toxin is composed of adenylate cyclase (EF) and MAPKK protease (LF) enzymatic components associated to protective antigen (PA) binding subunit. The binding and translocation components anthrax protective antigen (PA(63)) and C2II of C2 toxin share a sequence homology of about 35%, suggesting that they might substitute for each other. Here we show by conducting in vitro measurements that PA(63) binds C2I and that C2II can bind both EF and LF. Anthrax edema factor (EF) and lethal factor (LF) have higher affinities to bind to channels formed by C2II than C2 toxin's C2I binds to anthrax protective antigen (PA(63)). Furthermore, we could demonstrate that PA in high concentration has the ability to transport the enzymatic moiety C2I into target cells, causing actin modification and cell rounding. In contrast, C2II does not show significant capacity to promote cell intoxication by EF and LF. Together, our data unveiled the remarkable flexibility of PA in promoting C2I heterologous polypeptide translocation into cells.
KW  - Lipid bilayer-membranes
KW  - Current noise-analysis
KW  - Matrix protein porin
KW  - Clostridium-botulinum
KW  - Lethal factor
KW  - Edema factor
KW  - Escherichia-coli
KW  - Crystal-structure
KW  - Ion-channel
KW  - Phenylalanine clamp
Y1  - 2011
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-134791
VL  - 6
IS  - 8
ER  - 
TY  - JOUR
A1  - Wu, Yu
A1  - Pons, Valérie
A1  - Goudet, Amélie
A1  - Panigai, Laetitia
A1  - Fischer, Annette
A1  - Herweg, Jo-Ana
A1  - Kali, Sabrina
A1  - Davey, Robert A.
A1  - Laporte, Jérôme
A1  - Bouclier, Céline
A1  - Yousfi, Rahima
A1  - Aubenque, Céline
A1  - Merer, Goulven
A1  - Gobbo, Emilie
A1  - Lopez, Roman
A1  - Gillet, Cynthia
A1  - Cojean, Sandrine
A1  - Popoff, Michel R.
A1  - Clayette, Pascal
A1  - Le Grand, Roger
A1  - Boulogne, Claire
A1  - Tordo, Noël
A1  - Lemichez, Emmanuel
A1  - Loiseau, Philippe M.
A1  - Rudel, Thomas
A1  - Sauvaire, Didier
A1  - Cintrat, Jean-Christophe
A1  - Gillet, Daniel
A1  - Barbier, Julien
T1  - ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments
JF  - Scientific Reports
N2  - Intracellular pathogenic microorganisms and toxins exploit host cell mechanisms to enter, exert their deleterious effects as well as hijack host nutrition for their development. A potential approach to treat multiple pathogen infections and that should not induce drug resistance is the use of small molecules that target host components. We identifed the compound 1-adamantyl (5-bromo-2-methoxybenzyl) amine (ABMA) from a cell-based high throughput screening for its capacity to protect human cells and mice against ricin toxin without toxicity. This compound efciently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite. ABMA provokes Rab7-positive late endosomal compartment accumulation in mammalian cells without affecting other organelles (early endosomes, lysosomes, the Golgi apparatus, the endoplasmic reticulum or the nucleus). As the mechanism of action of ABMA is restricted to host-endosomal compartments, it reduces cell infection by pathogens that depend on this pathway to invade cells. ABMA may represent a novel class of broad-spectrum compounds with therapeutic potential against diverse severe infectious diseases.
KW  - biology
KW  - antimicrobials
KW  - high-throughput screening
KW  - infectious diseases
Y1  - 2017
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-173170
VL  - 7
ER  -